- Home
- LTRN vs CDTX Comparison
LTRN vs CDTX Comparison
Compare LTRN & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- CDTX
- Stock Information
- Founded
- LTRN 2013
- CDTX 2012
- Country
- LTRN United States
- CDTX United States
- Employees
- LTRN N/A
- CDTX N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LTRN Health Care
- CDTX Health Care
- Exchange
- LTRN Nasdaq
- CDTX Nasdaq
- Market Cap
- LTRN 37.5M
- CDTX 74.7M
- IPO Year
- LTRN 2020
- CDTX 2015
- Fundamental
- Price
- LTRN $3.39
- CDTX $11.15
- Analyst Decision
- LTRN Hold
- CDTX Strong Buy
- Analyst Count
- LTRN 1
- CDTX 4
- Target Price
- LTRN N/A
- CDTX $29.67
- AVG Volume (30 Days)
- LTRN 36.7K
- CDTX 17.7K
- Earning Date
- LTRN 11-06-2024
- CDTX 10-31-2024
- Dividend Yield
- LTRN N/A
- CDTX N/A
- EPS Growth
- LTRN N/A
- CDTX N/A
- EPS
- LTRN N/A
- CDTX N/A
- Revenue
- LTRN N/A
- CDTX $53,870,000.00
- Revenue This Year
- LTRN N/A
- CDTX N/A
- Revenue Next Year
- LTRN N/A
- CDTX N/A
- P/E Ratio
- LTRN N/A
- CDTX N/A
- Revenue Growth
- LTRN N/A
- CDTX N/A
- 52 Week Low
- LTRN $2.38
- CDTX $10.00
- 52 Week High
- LTRN $11.99
- CDTX $24.40
- Technical
- Relative Strength Index (RSI)
- LTRN 38.44
- CDTX 52.34
- Support Level
- LTRN $3.30
- CDTX $10.14
- Resistance Level
- LTRN $3.64
- CDTX $10.95
- Average True Range (ATR)
- LTRN 0.26
- CDTX 0.45
- MACD
- LTRN -0.02
- CDTX 0.06
- Stochastic Oscillator
- LTRN 35.90
- CDTX 100.00
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.